I think today we has a late reaction to news from yesterday..
SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Scientific, Inc.(GBSN) , a molecular diagnostics company, today announced it has initiated a clinical trial for its sample-to-result Bordatella Direct Test, which will detect, directly from patient specimen, Bordatella pertussis, a bacteriumcausing a highly contagious respiratory disease commonly known as whooping cough. This is the first of five clinical trials the Company plans to initiate in 2016.
"This is the first of five clinical trials the Company plans to initiate in 2016" looks like they are getting busy this year, with more news to come.
Traders are rotating from sector to sector, shippers wore in play last few days, now it may be time for biofuels to start moving. With a chart like this one has, and the small float size, this one can really take off once it gets started. GEVO looks like already started.